Beneficial Effects of Angiotensin II Receptor Blockers on Mortality in Patients with COVID-19: A Retrospective Study from 2019 to 2020 in China
ConclusionsARB administration was significantly associated with a lower risk of all-cause mortality in patients with COVID-19 and CVDs.Trial registrationClinicalTrials.gov NCT05615792.https://www.clinicaltrials.gov/ct2/show/NCT05615792
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | China Health | COVID-19 | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Heart Failure | International Medicine & Public Health | Pandemics | Study